Health Care

Bristol Myers to buy Karuna Therapeutics for $14B

Karuna’s crown jewel, an experimental drug called KarXT, is the product of such new insights. The drug could surpass $6 billion in yearly sales if it is approved for the various uses.

More eyedrops recalled after FDA warning

Another company issued a recall for eye drops after Food and Drug Administration investigators warned that unsanitary conditions could have contaminated dozens of products.